Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Abatacept halts RA progression early in high-risk group
Treatment with abatacept for a year halts disease progression in high-risk patients presenting with signs of imminent onset of rheumatoid arthritis (RA) in the phase IIb APIPPRA trial.
Abatacept halts RA progression early in high-risk group
20 Jun 2023
Dual-target oral drug outperforms tofacitinib in RA treatment
The novel, highly selective dual JAK1/TYK2 inhibitor TLL-018 appears to have better efficacy than the currently approved JAK inhibitor tofacitinib in the treatment of patients with rheumatoid arthritis (RA), according to the results of a head-to-head trial presented at EULAR 2023.
Dual-target oral drug outperforms tofacitinib in RA treatment
19 Jun 2023
Pain mechanisms tied to disease activity in DMARD-treated RA
A recent study has shown the importance of identifying and treating aberrant peripheral and central pain regulation in patients with rheumatoid arthritis (RA) who are either initiating or switching to disease-modifying antirheumatic drug (DMARD) treatment.
Pain mechanisms tied to disease activity in DMARD-treated RA
15 Jun 2023
Poor sleep quality burdens patients with juvenile fibromyalgia syndrome
Patients with juvenile fibromyalgia syndrome (JFS) often complain of sleep problems, which have a significant impact on clinical domains of the disease, including depression and pain, reports a study.
Poor sleep quality burdens patients with juvenile fibromyalgia syndrome
14 Jun 2023
Depression, anxiety symptoms saddle adolescents with JIA
Adolescents with juvenile idiopathic arthritis (JIA) remain vulnerable to symptoms of depression and anxiety, particularly panic, according to a study, noting the ongoing need for mental health screening protocols and services in this population.
